• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Xstrahl Medical
Pin It

Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the American Academy of Dermatology (AAD) annual meeting in Washington from March 1st to 5th.

The RADiant system is a small and compact unit specifically designed for use by dermatologists.

RADiant is a dual modality treatment system offering both superficial radiotherapy and electronic brachytherapy treatment options.

"RADiant expands the dermatologists' non-melanoma skin cancer treatment options with the latest dual modality radiotherapy technology," says Adrian Treverton, CEO of Xstrahl. "RADiant offers an extremely effective treatment option for when Mohs is not available, or the patient is unsuitable for surgery."

With the RADiant system, treatment delivery is fast, convenient and pain free. Patient visit time is kept to a minimum, typically 15 minutes including setup and treatment, leaving them free to continue with their normal daily activities. Advanced features such as illuminated halo applicators and an intuitive clinical dashboard provide physicians with meticulous control to deliver superior, surgical quality results.  

For ore details, http://www.xstrahl.com

Company Name: Xstrahl Group
About Company: Xstrahl is a leading designer and manufacturer of superficial orthovoltage medical X-ray systems used in the treatment of cancers and dermatological disorders. Headquartered in the UK with manufacturing facilities both in the UK and USA, Xstrahl operates globally through its international network of distributors.
Person of Contact: Neil Madle
Phone: +44 7776 659529

We use cookies to ensure you get the best experience on this website Privacy Policy